Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.

Atherosclerosis - 1 Feb 1999

Wartiovaara U, Perola M, Mikkola H, Tötterman K, Savolainen V, Penttilä A, Grant P J, Tikkanen M J, Vartiainen E, Karhunen P J, Peltonen L, Palotie A

Abstract excerpt

Factor XIII is a transglutaminase that crosslinks fibrin in the last steps of the coagulation process. A few polymorphic sites have been identified in this gene, one of them being a point mutation (FXIII Val34Leu), leading to an amino acid change of valine to leucine. Recently, in British patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Primers
Share to Factor XIII
Share to Fibrinolysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Finland

Share to Incidence

Share to Myocardial Infarction

Share to Plasminogen Activator Inhibitor 1

Share to Prevalence

Source

Identifiers

PMID: 10030380
DOI: 10.1016/s0021-9150(98)00241-x

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10030380-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.PMID 10030380Read ↗

The association between factor XIII Val34Leu polymorphism and early myocardial infarction.Semantic proximity Read ↗

Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.Semantic proximity Read ↗

Factor XIII val34leu and the risk of myocardial infarction.Semantic proximity Read ↗

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.Semantic proximity Read ↗

Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.Semantic proximity Read ↗

Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.Semantic proximity Read ↗

Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.Semantic proximity Read ↗

Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.Semantic proximity Read ↗

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.Semantic proximity Read ↗

Association of a Common Polymorphism in the Factor XIII Gene with Myocardial InfarctionSemantic proximity Read ↗

Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.Semantic proximity Read ↗

Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.